-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
-
ΑΛΕΞ ΜΠΟΝΤΙ και SCANDIC PAY: κάρτες Mastercard και VISA — μια νέα γενιά πληρωμών
-
ALEX BODI i SCANDIC PAY: karty Mastercard i VISA — nowa generacja płatności
-
АЛЕКС БОДІ та SCANDIC PAY: картки Mastercard і VISA — нове покоління платежів
-
АЛЕКС БОДИ и SCANDIC PAY: карты Mastercard и VISA — новое поколение платежей
-
ALEX BODI and SCANDIC PAY: Mastercard and VISA Cards – A New Generation of Payments
-
ALEX BODI și SCANDIC PAY: Cardurile Mastercard și VISA – o nouă generație de plăți
-
AI Bots and Plagiarism: How Philadelphia and New Jersey News Sites Are Using Fake Content
-
UK House Prices Fall 1.2% as London Records Sharpest Annual Decline
-
The Dice Box Recommends Winter Board Games for Sneinton Market Lounge
-
Get Huge: Looksmaxxing to Death Docuseries Details Tony Huge's Thailand Crimes
-
Government Overspends €607 Million on International Protection Accommodation in 2024
-
IIM Indore Announces IPMAT 2027 Exam Date for April 24
-
Palestinians Salvage Cultural Heritage from Gaza Rubble Amid Widespread Destruction
-
Quick Pressure-Cooker Beef Stew and Rice Minestrone Soup Recipes
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Route1 Announces 2026 Annual Meeting Results
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Patriot Software Adds Performance Reviews to Patriot HR
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Marketing Worldwide Corporation (OTC:MWWC) Announces 1-for-350 Reverse Stock Split Effective November 11, 2026
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
Aptevo Therapeutics Announces Exercise of Existing Warrants for $3.0 Million Gross Proceeds
-
Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion
-
6 Pieces of Furniture Worth Investing In
-
LiveOne (Nasdaq: LVO) to Report Second Quarter Fiscal 2027 Financial Results on November 12, 2026
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
PillSafe Founders' Interview Featured on Bloomberg, Fox Business, and Nasdaq
The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse, and protects patients and doctors, leading the fight against the opioid crisis.
In an exclusive in-depth interview broadcast on Bloomberg, Fox Business and Nasdaq, PillSafe's founders, Dr. John Barr and Jim Patton, discussed how its smart pill delivery system targets the critical issues of patient medicine monitoring and unused prescriptions, identified as key factors driving opioid misuse. Their revolutionary, disruptive technology helps to ensure safety and prescription compliance in the fight against opioids and other addictive drugs.
"It is an honor to share how PillSafe can help protect patients with our single-use and disposable containers," said Dr. Barr. "This interview allows us to go into details on how PillSafe came to be and our goal to make an impact regarding the opioid crisis and counterfeit medications."
The interview with Jane King addresses the need for safety measures related to medicinal intake, covers how PillSafe can benefit patients and various organizations and highlights the significance of its impact as a preventive measure against accidental overdoses.
In discussing how PillSafe differs from other pill delivery systems, Dr. Barr describes creating a bottle cap that is child- and adult-proof, the first major improvement in pill bottles since 1959's invention of the childhood cap. He then relates the unique features of the PillSafe bottle, including security against any breach.
The interview explores the backgrounds of its two founders:
Dr. John Barr practiced family medicine in North Carolina for over 30 years, obstetrics for eight years and worked hundreds of hours in emergency rooms. To help alleviate his patients' pain and suffering, he followed published studies that suggested the risk of addiction to opioids to be less than 1% for people without prior addiction. However, a prescription drug epidemic led to the suspension of Dr. Barr's license in 2012. He turned his attention to prescription bottles and how patients could overdose, share, sell or trade pills for illicit drugs. Dr. Barr researched and developed an idea regarding a theft deterrent system. In 2013, he teamed up with Jim Patton to create a management team and bring innovation to the market.
Jim Patton served as an officer in the U.S. Army before starting a career in orthopedic sales. In 1996, Patton founded Joint Technology Inc./Revert Systems, an orthopedic conservative care company helping patients increase their activity levels and decrease their pain levels using non-narcotic and non-invasive devices. In 2013, he met Dr. Barr, who shared his concerns about the opiate epidemic. Patton's 30-plus years as a successful marketer of conservative medical devices and Dr. Barr's 30-plus years in family medicine treating chronic pain led to the creation of PillSafe.
The interview also examines who can benefit from the PillSafe technology besides patients and their families. As a former military officer, Patton expresses concerns over veterans on medications with terrible side effects. Dr. Barr points out that insurance companies, pharmacies and governments are looking for solutions to the opioid and illicit drug crisis and the high cost related to medication non-compliance and claims of negligence.
Other topics covered in the interview include the impact of opiate addiction on the economy and the goal of PillSafe to help organizations and governments fight the opioid crisis and counterfeit illegal drugs.
The interview can be viewed here.
PillSafe has a revenue share opportunity to help them fund programs and can license their innovation technology to support this important cause against drug use. To learn more about the benefits of PillSafe, please visit https://pillsafeprotection.com.
About PillSafe
PillSafe is a pioneering "smart" technology that shifts the standard of care in the pharmaceutical industry with home delivery and patient compliance in response to the opioid epidemic. The company creates prescription compliance by restricting access to medication to only the patient, keeping medication safe from divergence and abuse. PillSafe's "intelligent" design includes several innovative features that benefit the delivery network from the manufacturer to the pharmacy to the patient. The patented technology includes an electronic label that can increase adherence messaging, two-step verification, or active advertising from the manufacturer to the pharmacy to the patient.
Contact Information
Jessica Lombao
Media Advantage Account Manager
[email protected]
Related Images
|
SOURCE: PillSafe
B.Torres--AT


